Home » An on-chip nanotech lab to evaluate blood-borne brain trauma

An on-chip nanotech lab to evaluate blood-borne brain trauma

by admin

A useful project on several fronts

Stefano Peroncini, CEO of the venture capital Eureka! Venture Sgr, which manages the Eureka! Fund I – Technology Transfer, investor in Inta has no doubts about the future prospects of this “hi-tech” project, even in very different sectors: “The researchers have developed the prototype of an innovative diagnostic tool, the so-called lab-on- chip, for the analysis of fluids with characteristics such as being truly portable, non-invasive and with numerous applications in various fields including biomedical, safety, industry 4.0 and food-analysis. Moreover, the same tool can also be used to detect other so-called “bio-analytes”, such as viruses and bacteria. So I would say a project very much in line with the times of the pandemic. We will soon announce a third important closing of the Eureka fund! I for over 11 million euros, thanks to new institutional investors, which will allow us to well exceed the initial funding target we had of 50 million euros ».

The spinoff was founded in April 2020 by an excellent team composed of Matteo Agostini, PhD in Molecular biophysics, researcher at Scuola Normale Superiore, Marco Cecchini, PhD in Condensed Matter Physics first researcher of Cnr-Nano, and Marco Calderisi, PhD in Metabolomics, with the aim of revolutionizing the world of high precision portable diagnostics.

«The entrance of Eureka! and A11 will allow us to speed up Inta’s growth path, to rapidly reach the development and commercialization of our technology. The contribution of the investment funds will be essential to better undertake the university-industry technology transfer and create new opportunities for professional and commercial development – points out Agostini, co-founder and CEO of INTA ».

See also  Colombia's Health Care System Drops in Global Ranking: What Changed?

On the same wavelength is Anna Amati, Partner of Eureka! Venture Sgr: «We are really pleased to have met Matteo and the Inta team on our path. Working with them in this period, we appreciated their seriousness, competence, passion and determination in wanting to bring to the market the results of their extraordinary research activity that we hope will really create a strong and positive impact on a global scale “.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy